BE1000168A3 - Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol. - Google Patents
Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol. Download PDFInfo
- Publication number
- BE1000168A3 BE1000168A3 BE8700817A BE8700817A BE1000168A3 BE 1000168 A3 BE1000168 A3 BE 1000168A3 BE 8700817 A BE8700817 A BE 8700817A BE 8700817 A BE8700817 A BE 8700817A BE 1000168 A3 BE1000168 A3 BE 1000168A3
- Authority
- BE
- Belgium
- Prior art keywords
- weight
- sorbitol
- pharmaceutical composition
- acetyl
- aspartame
- Prior art date
Links
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 title claims abstract description 20
- 239000000600 sorbitol Substances 0.000 title claims abstract description 20
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 11
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 title claims abstract description 7
- 229960004308 acetylcysteine Drugs 0.000 title claims abstract 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 title description 2
- 239000000126 substance Substances 0.000 claims abstract description 21
- 108010011485 Aspartame Proteins 0.000 claims abstract description 18
- 239000000605 aspartame Substances 0.000 claims abstract description 18
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 18
- 229960003438 aspartame Drugs 0.000 claims abstract description 18
- 235000010357 aspartame Nutrition 0.000 claims abstract description 18
- 239000004549 water soluble granule Substances 0.000 claims abstract 2
- 239000008187 granular material Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 11
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- OENHQHLEOONYIE-UKMVMLAPSA-N beta-Carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 241000207199 Citrus Species 0.000 description 2
- 244000248349 Citrus limon Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000000510 mucolytic effect Effects 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000001046 green dye Substances 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- 239000001048 orange dye Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000004173 sunset yellow FCF Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH2974/86A CH666814A5 (it) | 1986-07-24 | 1986-07-24 | Composizione farmaceutica idrosolubile contenente n-acetil-cisteina. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE1000168A3 true BE1000168A3 (fr) | 1988-07-05 |
Family
ID=4245819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE8700817A BE1000168A3 (fr) | 1986-07-24 | 1987-07-23 | Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol. |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE1000168A3 (enrdf_load_stackoverflow) |
| CH (1) | CH666814A5 (enrdf_load_stackoverflow) |
| DE (1) | DE3723734A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2601875B1 (enrdf_load_stackoverflow) |
| GB (1) | GB2192789B (enrdf_load_stackoverflow) |
| IT (1) | IT1222103B (enrdf_load_stackoverflow) |
| NL (1) | NL194154C (enrdf_load_stackoverflow) |
| SE (1) | SE500493C2 (enrdf_load_stackoverflow) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1217445B (it) * | 1988-04-29 | 1990-03-22 | Altergon Sa | Composizione farmaceutiche orosolubili contenti acetilcisteina |
| CH674940A5 (enrdf_load_stackoverflow) * | 1988-05-05 | 1990-08-15 | Ibsa Inst Biochimique Sa | |
| DE3909049A1 (de) * | 1989-03-18 | 1990-09-20 | Arthur Boskamp | Praeparat und dessen verwendung |
| US5296500A (en) * | 1991-08-30 | 1994-03-22 | The Procter & Gamble Company | Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy |
| IT1256616B (it) * | 1992-12-02 | 1995-12-12 | Zambon Spa | Sciroppo contenente n-acetil-cisteina |
| GB9226729D0 (en) * | 1992-12-22 | 1993-02-17 | Wellcome Found | Therapeutic combination |
| DE4406261C2 (de) * | 1993-08-31 | 1996-07-04 | Deutsches Krebsforsch | Verwendung von Thiolverbindungen zur Verminderung der Körperfettmenge |
| DE4329857C2 (de) * | 1993-09-03 | 1995-08-24 | Deutsches Krebsforsch | Verbindung zur Stärkung des Immunsystems und von Immunreaktionen |
| BE1007926A3 (fr) * | 1994-01-31 | 1995-11-21 | Zambon Int Pharma | Composition pharmaceutique contenant de la n-acetyl-cysteine. |
| US5451405A (en) * | 1994-04-25 | 1995-09-19 | Chesebrough-Pond's Usa Co. | Skin treatment composition |
| WO2000018392A1 (en) * | 1998-09-25 | 2000-04-06 | Glycox Corporation Limited | Fructosamine oxidase: antagonists and inhibitors |
| EP1115842A4 (en) | 1998-09-25 | 2002-08-21 | Glycox Corp Ltd | Fructosamine oxidase assay: methods and materials |
| EP1293251A1 (en) * | 2001-09-14 | 2003-03-19 | Holland Sweetener Company V.o.F. | Process for the production of alpha-L-aspartyl-l-phenylalanine methyl ester powder |
| EP2500018B1 (en) | 2002-03-08 | 2017-07-19 | PhilERA New Zealand Limited | Preventing and/or Treating Cardiovascular Disease and/or Associated Heart Failure |
| MXPA05002883A (es) | 2002-08-20 | 2005-10-05 | Protemix Corp Ltd | Formas de dosis y terapias relacionadas. |
| CA2577634C (en) | 2004-07-19 | 2015-07-07 | Protemix Corporation Limited | Synthesis of triethylenetetramines |
| GR1007236B (el) * | 2009-12-07 | 2011-04-08 | Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, | Νεα φαρμακευτικη συνθεση κοκκιων ν - ακετυλοκυστεϊνης και μεθοδος παραγωγης αυτων |
| IT1399492B1 (it) * | 2010-04-13 | 2013-04-19 | Alpex Pharma Sa | Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina. |
| CN103142505B (zh) * | 2013-03-29 | 2015-03-11 | 山东罗欣药业集团股份有限公司 | 一种乙酰半胱氨酸组合物颗粒剂及其制备方法 |
| ES2877679T3 (es) | 2017-12-31 | 2021-11-17 | Abdi Ibrahim Ilac Sanayi Ve Ticaret A S | Composición farmacéutica que comprende acetilcitisteína sin metilparabeno ni propilparabeno |
| CN113559078A (zh) * | 2021-07-02 | 2021-10-29 | 安徽省先锋制药有限公司 | 一种乙酰半胱氨酸泡腾片的制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1617638A1 (de) * | 1967-05-24 | 1971-05-13 | Miles Lab | Tablettenbindemittel |
| EP0125634A1 (de) * | 1983-05-13 | 1984-11-21 | Reichert, Dietrich, Dr. med. | Verwendung einer sekretolytisch wirkenden Substanz zur Herstellung eines Antischnarchmittels und zur Bekämpfung des Schnarchphänomens |
| CH646843A5 (en) * | 1982-02-17 | 1984-12-28 | Xyrofin Ag | Sugar substitute, method for its production, and its use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3317530A1 (de) * | 1983-05-13 | 1984-11-15 | Dietrich Dr.med. Sta. Eulalia Ibiza Reichert | Antischnarchmittel |
| DE3317558A1 (de) * | 1983-05-13 | 1984-11-15 | Dietrich Dr.med. Sta. Eulalia Ibiza Reichert | Orales antischnarchmittel |
| IT1170268B (it) * | 1983-12-21 | 1987-06-03 | Zambon Spa | Uso dell'acetilcisteina per ridurre l'incremento della prolieferazione delle cellule basali dell'epitelio respiratoriotracheo-bronchiale indotto dal fumo di tabacco nei mammiferi |
| DE3514995A1 (de) * | 1985-04-25 | 1986-10-30 | Protopharma Ltd., 7831 Malterdingen | Verwendung von sulfydrylarzneimitteln zur bekaempfung von schaedigungen der magenschleimhaut |
-
1986
- 1986-07-24 CH CH2974/86A patent/CH666814A5/it not_active IP Right Cessation
-
1987
- 1987-07-17 DE DE19873723734 patent/DE3723734A1/de active Granted
- 1987-07-22 FR FR878710367A patent/FR2601875B1/fr not_active Expired - Lifetime
- 1987-07-23 IT IT21410/87A patent/IT1222103B/it active
- 1987-07-23 SE SE8702941A patent/SE500493C2/sv not_active IP Right Cessation
- 1987-07-23 BE BE8700817A patent/BE1000168A3/fr not_active IP Right Cessation
- 1987-07-23 NL NL8701744A patent/NL194154C/nl not_active IP Right Cessation
- 1987-07-24 GB GB8717581A patent/GB2192789B/en not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1617638A1 (de) * | 1967-05-24 | 1971-05-13 | Miles Lab | Tablettenbindemittel |
| CH646843A5 (en) * | 1982-02-17 | 1984-12-28 | Xyrofin Ag | Sugar substitute, method for its production, and its use |
| EP0125634A1 (de) * | 1983-05-13 | 1984-11-21 | Reichert, Dietrich, Dr. med. | Verwendung einer sekretolytisch wirkenden Substanz zur Herstellung eines Antischnarchmittels und zur Bekämpfung des Schnarchphänomens |
Non-Patent Citations (1)
| Title |
|---|
| DICTIONNAIRE VIDAL, 61ième édition, 1985, page 551, O.V.P. Paris, FR; "Exomuc" * |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2601875A1 (fr) | 1988-01-29 |
| GB8717581D0 (en) | 1987-09-03 |
| NL8701744A (nl) | 1988-02-16 |
| CH666814A5 (it) | 1988-08-31 |
| SE8702941D0 (sv) | 1987-07-23 |
| GB2192789A (en) | 1988-01-27 |
| NL194154C (nl) | 2001-08-03 |
| SE8702941L (sv) | 1988-01-25 |
| IT1222103B (it) | 1990-08-31 |
| NL194154B (nl) | 2001-04-02 |
| FR2601875B1 (fr) | 1992-02-21 |
| DE3723734C2 (enrdf_load_stackoverflow) | 1992-05-21 |
| SE500493C2 (sv) | 1994-07-04 |
| DE3723734A1 (de) | 1988-02-04 |
| IT8721410A0 (it) | 1987-07-23 |
| GB2192789B (en) | 1990-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1000168A3 (fr) | Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol. | |
| FR2601876A1 (fr) | Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique | |
| JP2874967B2 (ja) | 本質的に水に不溶な薬剤活性体のための薬剤水懸濁液 | |
| AT396426B (de) | Feste pharmazeutische ranitidinpräparate | |
| EP0759296B1 (de) | Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz | |
| EP0481294B2 (de) | Feste, schnell-lösliche Arzneimittelzubereitung enthaltend N-Acetylcystein | |
| BE1015217A5 (enrdf_load_stackoverflow) | ||
| FR2724844A1 (fr) | Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation | |
| CA2017360A1 (fr) | Forme pharmaceutique poreuse et sa preparation | |
| CA2403594A1 (en) | Granules having good taking property | |
| CZ170296A3 (en) | Organoleptic acceptable pharmaceutical preparation for peroral administration | |
| JP2705787B2 (ja) | 苦味改善易服用性ｈ▲２▼ブロッカー固形製剤 | |
| KR20070049962A (ko) | 경구 고형 제제 및 그의 제조 방법 | |
| WO2004032942A1 (fr) | Formulation orale seche a visee phlebotonique et vasculoprotectrice pour le traitement de l'insuffisance veineuse, de la fragilite capillaire et de la crise hemorroidaire, sous forme pharmaceutique de comprime a croquer contenant de la diosmine | |
| EP0468245B1 (de) | Tablette und Granulat welche als Wirkstoff Mesna enthalten | |
| KR100929320B1 (ko) | 리바비린 시럽 제형 | |
| JP3935934B2 (ja) | イチョウの葉の乾操抽出物を含有する発泡性飲食用組成物 | |
| EP1129709B1 (en) | Pharmaceutical composition based on ibuprofen and a procedure for the preparation thereof | |
| KR101175120B1 (ko) | 나테글리니드 함유 제제 | |
| EA012324B1 (ru) | Быстрораспадающаяся таблетка | |
| HU191542B (en) | Process for production of pastiles containing dipyridamel independent from ph with regulated output of the active substance | |
| EP0319074A1 (en) | Pharmaceutical composition and process for its preparation | |
| FR2753097A1 (fr) | Gel aqueux ou hydroalcoolique extemporane a viscosite controlee | |
| JPH0256416A (ja) | 苦味を抑えた顆粒剤 | |
| JP2014227366A (ja) | 圧縮成形製剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE20 | Patent expired |
Owner name: S.A. *INPHARZAM Effective date: 20070723 |